Quantcast

Bayer Monsanto Damages Reduced to $25.27 Million by U.S. Judge

Health + Wellness
The compound of German chemicals and pharmaceuticals giant Bayer in Berlin. ODD ANDERSEN / AFP / Getty Images

U.S. District Judge Vince Chhabria announced his ruling in San Francisco on Monday.


Chhabria reduced the amount that Germany's Bayer AG has to pay the claimant to $25.27 million (€22.4 million). Bayer bought Roundup maker Monsanto for $63 billion last year.

Following a four-week trial in March a federal jury awarded $5 million (€4.4 million) in compensatory and $75 million in punitive damages to a man who blamed his cancer on glyphosate-based weed killer Roundup.

Edwin Hardeman was diagnosed with non-Hodgkin's lymphoma in 2014.

Limits on Ratios for Damages

At a hearing to discuss Bayer's request to overturn the verdict earlier this month, Chhabria said, "It's quite clear that under the Constitution I'm required to reduce the punitive damages award and it's just a question of how much."

U.S. Supreme Court rulings limit the ratio of punitive to compensatory damages to 9 to 1.

The judge said he would also take into account the fact that Hardeman was now in full remission and unlikely to suffer as much as he had in the past.

Bayer says Roundup — and its active ingredient glyphosate — are safe for human use and not carcinogenic. However, in 2015 the World Health Organization's cancer arm reached a different conclusion, classifying glyphosate as "probably carcinogenic to humans."

Roundup products for sale in California.


Litigation Hits Share Price

The Leverkusen-based company is facing lawsuits from more than 13,400 plaintiffs in the U.S.

Earlier this year, Bayer CEO Werner Baumann conceded the effect the court cases had had on the share price: "We have lost two cases in lower courts. That is why the company is massively affected. You see it in our share price," he said at an academic business event in Cologne in April. "You see it selectively, mainly here in Germany and in France — less so in the USA — in our reputational scores."

Over the past year, Bayer's share price has dropped dramatically and the company has seen €30 billion (approximately $33.7 billion) wiped off its market value since the first court ruling last August. Its share price has fallen from €96 (approximately $108) in August 2018 to €58.63 (approximately $66) at close of markets in Frankfurt on Monday.

Reposted with permission from our media associate DW.

EcoWatch Daily Newsletter

Protesters march during a "Friday for future" youth demonstration in a street of Davos on Jan. 24 on the sideline of the World Economic Forum annual meeting. FABRICE COFFRINI / AFP / Getty Images

By Andrea Germanos

Youth climate activists marched through the streets of Davos, Switzerland Friday as the World Economic Forum wrapped up in a Fridays for Future demonstration underscoring their demand that the global elite act swiftly to tackle the climate emergency.

Read More
chuchart duangdaw / Moment / Getty Images

By Tim Radford

The year is less than four weeks old, but scientists already know that carbon dioxide emissions will continue to head upwards — as they have every year since measurements began leading to a continuation of the Earth's rising heat.

Read More
Sponsored
Lucy Lambriex / DigitalVision / Getty Images

By Katey Davidson

Each year, an estimated 600 million people worldwide experience a foodborne illness.

While there are many causes, a major and preventable one is cross-contamination.

Read More
picture alliance / dpa / F. Rumpenhorst

By Arthur Sullivan

When was the last time you traveled by plane? Various researchers say as little as between 5 and 10 percent of the global population fly in a given year.

Read More
A Starbucks barista prepares a drink at a Starbucks Coffee Shop location in New York. Ramin Talaie / Corbis via Getty Images

By Cathy Cassata

Are you getting your fill of Starbucks' new Almondmilk Honey Flat White, Oatmilk Honey Latte, and Coconutmilk Latte, but wondering just how healthy they are?

Read More